Clinical Trial Update: Juno Perth Clinical Trial [NA]

View source ↗

Summary

Clinical trial update for the Juno Perth study (NCT02317042) shows termination with results posted in 2021; no phase information available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Neuromuscular Disease
• Obesity Hypoventilation Syndrome
• Respiratory Insufficiency
• Upper Airway Obstruction

Snippet

Sponsor: ResMed | Conditions: Respiratory Insufficiency, Obesity Hypoventilation Syndrome | NA | Status: TERMINATED | Results posted: 2021-06-08